EFEllen Fragaszy

Ellen Fragaszy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ellen Fragaszy has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Comparison of Virus Watch COVID-19 Positivity, Incidence, and Hospitalization Rates With Other Surveillance Systems: Surveillance Study

    by Wing Lam Erica Fong, Vincent Grigori Nguyen, Sarah Beale, Thomas E Byrne, Cyril Geismar, Ellen Fragaszy, Jana Kovar, Alexei Yavlinsky, Ibrahim Abubakar, Andrew C Hayward, et al.

  • Open Access

    Comparison of Virus Watch COVID-19 Positivity, Incidence, and Hospitalization Rates With Other Surveillance Systems: Surveillance Study

    by Wing Lam Erica Fong, Vincent Grigori Nguyen, Sarah Beale, Thomas E Byrne, Cyril Geismar, Ellen Fragaszy, Jana Kovar, Alexei Yavlinsky, Ibrahim Abubakar, Andrew C Hayward, et al.

    Background: Effective disease surveillance is essential for understanding pathogens’ epidemiology, detecting outbreaks, and enabling timely public health responses. In the United Kingdom, large-scale studies, such as the Office for National Statistics COVID-19 Infection Survey (CIS), have monitored SARS-CoV-2 transmission but required significant resources, making them challenging to sustain when pandemic-specific funding ends and also in resource-limited settings. In contrast, the Virus Watch study, at lower cost, relied on self-reported and linked national testing data as well as symptomatic testing, while Severe Acute Respiratory Infections Watch (SARI) leveraged hospital data for cost-effective surveillance. Objective: This study aimed to evaluate the effectiveness of Virus Watch as a surveillance system in monitoring COVID-19 positivity, incidence, and hospitalization rates in England and Wales, using data from the CIS and SARI as benchmarks for comparison, while considering the key differences in the study designs, including recruitment strategies, incentives, and testing criteria. Methods: We used the Virus Watch prospective community cohort study to estimate COVID-19 positivity, incidence, and hospitalization rates in England and Wales from June 2020 to March 2023. Rate estimates were compared with CIS modeled positivity and incidence rates, and with SARI COVID-19 hospitalization rates. Global synchrony between datasets was measured using overall Spearman ⍴ and local synchrony using 9-week rolling Spearman ⍴. For England, comparisons with CIS estimates used Virus Watch rates calculated with and without linked national testing data. Positivity rates were also assessed overall and separately before and after the end of free national testing. Results: A total of 58,628 participants were recruited into the Virus Watch study, of whom 52,526 (89.6%) were resident in England and 1532 (2.6%) in Wales; region was missing for the remainder. Virus Watch–estimated COVID-19 positivity and incidence rates in England, calculated with and without linked testing data, showed strong global synchrony with CIS estimates (positivity ⍴: 0.91 and 0.90; both P <.001 and incidence ⍴: 0.92 and 0.90; both P <.001) and strong local synchrony (positivity ⍴: median 0.75, IQR 0.53‐0.85 and median 0.67, IQR 0.47‐0.83, and incidence ⍴: median 0.76, IQR 0.49‐0.88 and median 0.66, IQR 0.45‐0.82), despite having lower absolute values. Global and local synchrony of positivity rates were similar for periods before and after the end of free national testing, although the difference between Virus Watch and CIS estimates was greater post–free testing. COVID-19 hospitalization rates were also lower and less synchronized with SARI estimates. In Wales, Virus Watch estimates exhibited greater variability (positivity ρ: 0.75, P <.001; incidence rate ρ: 0.85, P <.001) and lower local synchrony (positivity ρ: median 0.61, IQR 0.34‐0.74, and incidence ρ: median 0.52, IQR 0.38‐0.71) compared to England. Conclusions: Our results highlight the effectiveness of the Virus Watch approach in providing accurate estimates of COVID-19 positivity and incidence rates, even in the absence of national surveillance systems. This low-cost method can be adapted to various settings, particularly low-resource ones, to strengthen public health surveillance and inform timely interventions.


  • Open Access

    Tracking COVID-19 in England and Wales: Insights from Virus Watch - a prospective community cohort study

    by Wing Lam Erica Fong, Vincent Grigori Nguyen, Sarah Beale, Thomas E Byrne, Cyril Geismar, Ellen Fragaszy, Jana Kovar, Annalan M D Navaratnam, Alexei Yavlinsky, Ibrahim Abubakar, et al.

    Background Virus Watch is a prospective community cohort study of COVID-19 of 28□,527 households in England and Wales designed to estimate the incidence of PCR-confirmed COVID-19 in those with respiratory presentations and examine symptom profiles and transmission of COVID-19 in relation to population movement and behaviour. The Office for National Statistics (ONS) COVID-19 infection survey (CIS) was the largest regular survey of COVID-19 infections and antibodies in the UK and included 227,797 households. In this analysis, we aimed to compare incidence rate estimates from the two studies to understand differences in estimates from the two study designs. Methods We used the Virus Watch prospective community cohort study to estimate the overall SARS-CoV-2 incidence rate and incidence rate by age in England and Wales from June 2020 to February 2023. Virus Watch data consisted of self-reported laboratory COVID-19 test results and linkage to the Second Generation Surveillance System, the UK national database for COVID-19 testing. We compared our findings with modelled incidence rates from ONS CIS using 3-day rolling Pearson’s correlation to measure synchrony. Results 58,628 participants were recruited into the Virus Watch study between June 2020 and March 2022, of whom 52,526 (90%) were reported to be living in England and 1,532 (2.6%) in Wales. COVID-19 incidence rates were initially similar across age groups until the Delta wave when rates increased at different magnitudes. During the Omicron BA.1, the 0-14 age group had the highest incidence rates, which shifted to the 25-44 age group with Omicron BA.2, 4, and 5 dominance. We found strong synchrony between Virus Watch and ONS CIS COVID-19 incidence estimates for England and Wales, both with and without the incorporation of linked national testing data into the Virus Watch study. In particular, the magnitude and trend of Virus Watch- and ONS-estimated rates for England were generally consistent, although Virus Watch-estimated peaks of infection during the Omicron BA.1 and 2 waves were found to be lower than estimates from the ONS. Conclusion Our findings suggest that the Virus Watch research approach is a low-cost and effective method for on-going surveillance of COVID-19 regardless of the availability of national testing in the UK. Similar approaches can also be utilised by low-resource settings to provide accurate incidence rate estimates to better monitor and respond to COVID-19 as well as other acute respiratory diseases in the future.

  • Open Access

    Assessing the causal effect of air pollution on risk of SARS-CoV-2 infection

    by Annalan Mathew Dwight Navaratnam, Sarah Beale, Yamina Boukari, Vincent Nguyen, Wing Lam Erica Fong, Isobel Braithwaite, Thomas E Byrne, Ellen Fragaszy, Cyril Geismar, Jana Kovar, et al.

    Introduction: Emerging evidence suggests association of air pollution exposure with risk of SARS-CoV-2 infection, but many of these findings are limited by study design, lack of individual-level covariate data or are specific to certain subpopulations. We aim to evaluate causal effects of air pollution on risk of infection, whilst overcoming these limitations. Methods: Concentrations for black carbon(BC), particulate matter 10(PM 10 ), particulate matter 2.5(PM 2.5 ), nitrogen dioxide(NO 2 ) and oxides of nitrogen(NO x ) from the Department of Environment, Food and Rural Affairs (DEFRA) and Effect of Low-level Air Pollution: A Study in Europe (ELAPSE) were linked to postcodes of 53,683 Virus Watch study participants. The primary outcome was first SARS-CoV-2 infection, between 1st September 2020 and 30th April 2021. Regression analysis used modified Poisson with robust estimates, clustered by household, adjusting for individual (e.g., age, sex, ethnicity) and environmental covariates(e.g., population density, region) to estimate total and direct effects. Results: Single pollutant analysis showed the direct effect of higher risk of SARS-CoV-2 infection with increased exposure to PM 2.5 (RR1.11,95%CI 1.08;1.15), PM 10 (RR1.06,95%CI 1.04;1.09), NO 2 (RR1.04,95%CI 1.04;1.05) and NO x (RR1.02,95%CI 1.02;1.02) per 1µg/m 3 increment with DEFRA 2015-19 data. Sensitivity analyses altering covariates, exposure window and modelled air pollution data source produced similar estimates. Higher risk of SARS-CoV-2 per 10 -5 m -1 increment of BC (RR1.86, 95%CI 1.62;2.14) was observed using ELAPSE data. Conclusion: Long term exposure to higher concentrations of air pollutions increases the risk of SARS-CoV-2 infection, highlighting that adverse health effects of air pollution is not only limited to non-communicable diseases.


  • Open Access

    Tracking Changes in Mobility Before and After the First SARS-CoV-2 Vaccination Using Global Positioning System Data in England and Wales (Virus Watch): Prospective Observational Community Cohort Study

    by Vincent Nguyen, Yunzhe Liu, Richard Mumford, Benjamin Flanagan, Parth Patel, Isobel Braithwaite, Madhumita Shrotri, Thomas Byrne, Sarah Beale, Anna Aryee, et al.

    Background: Evidence suggests that individuals may change adherence to public health policies aimed at reducing the contact, transmission, and spread of the SARS-CoV-2 virus after they receive their first SARS-CoV-2 vaccination when they are not fully vaccinated. Objective: We aimed to estimate changes in median daily travel distance of our cohort from their registered addresses before and after receiving a SARS-CoV-2 vaccine. Methods: Participants were recruited into Virus Watch starting in June 2020. Weekly surveys were sent out to participants, and vaccination status was collected from January 2021 onward. Between September 2020 and February 2021, we invited 13,120 adult Virus Watch participants to contribute toward our tracker subcohort, which uses the GPS via a smartphone app to collect data on movement. We used segmented linear regression to estimate the median daily travel distance before and after the first self-reported SARS-CoV-2 vaccine dose. Results: We analyzed the daily travel distance of 249 vaccinated adults. From 157 days prior to vaccination until the day before vaccination, the median daily travel distance was 9.05 (IQR 8.06-10.09) km. From the day of vaccination to 105 days after vaccination, the median daily travel distance was 10.08 (IQR 8.60-12.42) km. From 157 days prior to vaccination until the vaccination date, there was a daily median decrease in mobility of 40.09 m (95% CI –50.08 to –31.10; P<.001). After vaccination, there was a median daily increase in movement of 60.60 m (95% CI 20.90-100; P<.001). Restricting the analysis to the third national lockdown (January 4, 2021, to April 5, 2021), we found a median daily movement increase of 18.30 m (95% CI –19.20 to 55.80; P=.57) in the 30 days prior to vaccination and a median daily movement increase of 9.36 m (95% CI 38.6-149.00; P=.69) in the 30 days after vaccination. Conclusions: Our study demonstrates the feasibility of collecting high-volume geolocation data as part of research projects and the utility of these data for understanding public health issues. Our various analyses produced results that ranged from no change in movement after vaccination (during the third national lock down) to an increase in movement after vaccination (considering all periods, up to 105 days after vaccination), suggesting that, among Virus Watch participants, any changes in movement distances after vaccination are small. Our findings may be attributable to public health measures in place at the time such as movement restrictions and home working that applied to the Virus Watch cohort participants during the study period.


  • Open Access

    Cohort profile: Virus Watch: Understanding community incidence, symptom profiles, and transmission of COVID-19 in relation to population movement and behaviour

    by Thomas Byrne, Jana Kovar, Sarah Beale, Isobel Braithwaite, Ellen Fragaszy, Wing Lam Erica Fong, Cyril Geismar, Susan Hoskins, Annalan M D Navaratnam, Vincent Nguyen, et al.

    Key Features Virus Watch is a national community cohort study of COVID-19 in households in England and Wales, established in June 2020. The study aims to provide evidence on which public health approaches are most effective in reducing transmission, and investigate community incidence, symptoms, and transmission of COVID-19 in relation to population movement and behaviours. 28,527 households and 58,628 participants of age (0-98 years, mean age 48), were recruited between June 2020 - July 2022 Data collected include demographics, details on occupation, co-morbidities, medications, and infection-prevention behaviours. Households are followed up weekly with illness surveys capturing symptoms and their severity, activities in the week prior to symptom onset and any COVID-19 test results. Monthly surveys capture household finance, employment, mental health, access to healthcare, vaccination uptake, activities and contacts. Data have been linked to Hospital Episode Statistics (HES), inpatient and critical care episodes, outpatient visits, emergency care contacts, mortality, virology testing and vaccination data held by NHS Digital. Nested within Virus Watch are a serology & PCR cohort study (n=12,877) and a vaccine evaluation study (n=19,555). Study data are deposited in the Office of National Statistics (ONS) Secure Research Service (SRS). Survey data are available under restricted access upon request to ONS SRS.


  • Open Access

    The incidence of COVID-19-related hospitalisation in migrants in the UK: Findings from the Virus Watch prospective community cohort study

    by Wing Lam Erica Fong, Vincent G Nguyen, Rachel Burns, Yamina Boukari, Sarah Beale, Isobel Braithwaite, Thomas E Byrne, Cyril Geismar, Ellen Fragaszy, Susan Hoskins, et al.

    Background Migrants in the UK may be at higher risk of SARS-CoV-2 exposure; however, little is known about their risk of COVID-19-related hospitalisation during waves 1-3 of the pandemic. Methods We analysed secondary care data linked to Virus Watch study data for adults and estimated COVID-19-related hospitalisation incidence rates by migration status. To estimate the total effect of migration status on COVID-19 hospitalisation rates, we ran fixed-effect Poisson regression for wave 1 (01/03/2020-31/08/2020; wildtype), and fixed-effect negative binomial regressions for waves 2 (01/09/2020-31/05/2021; Alpha) and 3 (01/06/2020-31/11/2021; Delta). Results of all models were then meta-analysed. Results Of 30,276 adults in the analyses, 26,492 (87.5%) were UK-born and 3,784 (12.5%) were migrants. COVID-19-related hospitalisation incidence rates for UK-born and migrant individuals across waves 1-3 were 2.7 [95% CI 2.2-3.2], and 4.6 [3.1-6.7] per 1,000 person-years, respectively. Pooled incidence rate ratios across waves suggested increased rate of COVID-19-related hospitalisation in migrants compared to UK-born individuals in unadjusted 1.68 [1.08-2.60] and adjusted analyses 1.35 [0.71-2.60]. Conclusion Our findings suggest migration populations in the UK have excess risk of COVID-19-related hospitalisations and underscore the need for more equitable interventions particularly aimed at COVID-19 vaccination uptake among migrants.


  • Open Access

    Relative contribution of essential and non-essential activities to SARS-CoV-2 transmission following the lifting of public health restrictions in England and Wales

    by Susan Hoskins, Sarah Beale, Vincent Nguyen, Yamina Boukari, Alexei Yavlinsky, Jana Kovar, Thomas Byrne, Ellen Fragaszy, Wing Lam Erica Fong, Cyril Geismar, et al.

    Purpose: We aimed to understand which non-household activities increased infection odds and contributed greatest to SARS-CoV-2 infections following the lifting of public health restrictions in England and Wales. Procedures: We undertook multivariable logistic regressions assessing the contribution to infections of activities reported by adult Virus Watch Community Cohort Study participants. We calculated adjusted weighted population attributable fractions (aPAF) estimating which activity contributed greatest to infections. Findings: Among 11 413 participants (493 infections), infection was associated with: leaving home for work (aOR 1.35 (1.11–1.64), aPAF 17%), public transport (aOR 1.27 (1.04–1.57), aPAF 12%), shopping once (aOR 1.83 (1.36–2.45)) vs. more than three times a week, indoor leisure (aOR 1.24 (1.02–1.51), aPAF 10%) and indoor hospitality (aOR 1.21 (0.98–1.48), aPAF 7%). We found no association for outdoor hospitality (1.14 (0.94–1.39), aPAF 5%) or outdoor leisure (1.14 (0.82–1.59), aPAF 1%). Conclusion: Essential activities (work and public transport) carried the greatest risk and were the dominant contributors to infections. Non-essential indoor activities (hospitality and leisure) increased risk but contributed less. Outdoor activities carried no statistical risk and contributed to fewer infections. As countries aim to ‘live with COVID’, mitigating transmission in essential and indoor venues becomes increasingly relevant.


  • Open Access

    Prevalence and Characteristics of Persistent Symptoms in Children During the COVID-19 Pandemic: Evidence From a Household Cohort Study in England and Wales

    by Faith Miller, Vincent Nguyen, Annalan Md Navaratnam, Madhumita Shrotri, Jana Kovar, Andrew C Hayward, Ellen Fragaszy, Robert W Aldridge, Pia Hardelid, on behalf of the VirusWatch Collaborative


  • Open Access

    A case-crossover study of the effect of vaccination on SARS-CoV-2 transmission relevant behaviours during a period of national lockdown in England and Wales

    by Aimee Serisier, Sarah Beale, Yamina Boukari, Susan Hoskins, Vincent Nguyen, Thomas Byrne, Wing Lam Erica Fong, Ellen Fragaszy, Cyril Geismar, Jana Kovar, et al.

    Background Studies of COVID-19 vaccine effectiveness show increases in COVID-19 cases within 14 days of a first dose, potentially reflecting post-vaccination behaviour changes associated with SARS-CoV-2 transmission before vaccine protection. However, direct evidence for a relationship between vaccination and behaviour is lacking. We aimed to examine the association between vaccination status and self-reported non-household contacts and non-essential activities during a national lockdown in England and Wales. Methods Participants (n=1,154) who had received the first dose of a COVID-19 vaccine reported non-household contacts and non-essential activities from February to March 2021 in monthly surveys during a national lockdown in England and Wales. We used a case-crossover study design and conditional logistic regression to examine the association between vaccination status (pre-vaccination vs. 14 days post-vaccination) and self-reported contacts and activities within individuals. Stratified subgroup analyses examined potential effect heterogeneity by sociodemographic characteristics such as sex, household income or age group. Results 457/1,154 (39.60%) participants reported non-household contacts post-vaccination compared with 371/1,154 (32.15%) participants pre-vaccination. 100/1,154 (8.67%) participants reported use of non-essential shops or services post-vaccination compared with 74/1,154 (6.41%) participants pre-vaccination. Post-vaccination status was associated with increased odds of reporting non-household contacts (OR 1.65, 95% CI 1.31-2.06, pConclusion Participants had higher odds of reporting non-household contacts and use of non-essential shops or services within 14 days of their first COVID-19 vaccine compared to pre-vaccination. Public health emphasis on maintaining protective behaviours during this post-vaccination time period when individuals have yet to develop full protection from vaccination could reduce risk of SARS-CoV-2 infection.